1.. 1.Illuminating Engineering Society of North America. American National Standard Practice for Industrial Lighting. American National Standards Institute, 1983: ANSI/IES RP-7,6,38.
2.. 2.Abrahamsson M, Sjostrand J. Impairment of contrast sensitivity function (CSF) as a measure of disability glare. Invest Ophthalmol Vis Sci. 1986;27:1131–1136. MEDLINE
3.. 3.Storch RL, Bodis-Wollner I. Overview of contrast sen sitivity and neuro-ophthalmic disease. In: Nadler MP, Miller D, Nadler DJ editor. Glare and contrast sensitivity for clinicians. New York: Springer-Verlag; 1990;p. 85–112.
4.. 4.Pepose JS, Ubels JL. The cornea. In: Hart WM editors. Adler's physiology of the eye. St. Louis: Mosby Year-Book; 1992;p. 29–70.
5.. 5.IJspeert JK, de Waard PW, van den Berg TJ, et al. The intraocular straylight function in 129 healthy volunteers: dependence on angle, age, and pigmentation. Vision Res. 1990;30:699–707. MEDLINE |
CrossRef
6.. 6.Nakagawara VB, Montgomery RW, Wood KJ. The applicability of commercial glare test devices in the aeromedical certification of pilot applicants. Washington, DC: U.S. Department of Transportation/Federal Aviation Administration, 1994. FAA Report No. DOT/FAA/AM-94-15. (Available from: National Technical Information Service, Springfield, Virginia 22161. Order #ADA 284232.)
7.. 7.van den Berg TJ, IJspeert JK, de Waard PW. Dependence of intraocular stray light on pigmentation and light transmission through the ocular wall. Vision Res. 1991;31:1361–1367. MEDLINE |
CrossRef
8.. 8.Bichao IC, Yager D, Meng J. Disability glare: effects of temporal characteristics of the glare source and of the visual-field location of the test stimulus. J Opt Soc Am A. 1995;12:2252–2258.
9.. 9.Owsley C, Stalvey BT, Wells J, et al. Visual risk factors for crash involvement in older drivers with cataract. Arch Ophthalmol. 2001;119:881–887. MEDLINE
10.. 10.Mantyjarvi M, Tuppurainen K. Cataract in traffic. Graefes Arch Clin Exp Ophthalmol. 1999;237:278–282.
CrossRef
11.. 11.Mainster MA, Timberlake GT. Why HID headlights bother older drivers. Br J Ophthalmol. 2003;87:113–117. MEDLINE |
CrossRef
12.. 12.Fong DS. Age-related macular degeneration: update for primary care. Am Fam Physician. 2000;61:3035–3042.
13.. 13.Faubert J, Overbury O. Binocular vision in older people with adventitious visual impairment: sometimes one eye is better than two. J Am Geriatr Soc. 2000;48:375–380. MEDLINE
14.. 14.Richer S. A protocol for the evaluation and treatment of atrophic age-related macular degeneration. J AM OPTOM ASSOC. 1999;70:13–23. MEDLINE
15.. 15.Lin S, Reiter K, Dreher AW, et al. The effect of pterygiaon contrast sensitivity and glare disability. Am J Oph thalmol. 1989;107:407–410.
16.. 16.Titiyal JS, Das A, Dada VK, et al. Visual performance of rigid gas-permeable contact lenses in patients with corneal opacity. CLAO J. 2001;27:163–165. MEDLINE
17.. 17.Jewelewicz DA, Evans R, Chen R, et al. Evaluation of night vision disturbances in contact lens wearers. CLAO J. 1998;24:107–110. MEDLINE
18.. 18.Miller D, Lazenby GW. Glare sensitivity in corrected aphakes. Ophthalmic Surg. 1977;8:54–57.
19.. 19.Harper RA, Halliday BL. Glare and contrast sensitivity in contact lens corrected aphakia, epikeratophakia, and pseudophakia. Eye. 1989;3(Pt. 5):562–570.
20.. 20.LeClaire J, Nadler MP, Weiss S, et al. A new glare tester for clinical testing: results comparing normal subjects and variously corrected aphakic patients. Arch Ophthalmol. 1982;100:153–158. MEDLINE
21.. 21.Alio JL, de la Hoz F, Perez-Santonja JJ, et al. Phakic anterior chamber lenses for the correction of myopia: a 7-year cumulative analysis of complications in 263 cases. Ophthalmology. 1999;106:458–466. Abstract | Full Text |
Full-Text PDF (434 KB)
|
CrossRef
22.. 22.Dick HB, Krummenauer F, Schwenn O, et al. Objective and subjective evaluation of photic phenomena after monofocal and multifocal intraocular lens implantation. Ophthalmology. 1999;106:1878–1886. Abstract | Full Text |
Full-Text PDF (507 KB)
|
CrossRef
23.. 23.Nadler DJ, Jaffe NS, dayman HM, et al. Glare disability in eyes with intraocular lenses. Am J Ophthalmol. 1984;97:43–47. MEDLINE
24.. 24.Tan JC, Spalton DJ, Arden GB. Comparison of methods to assess visual impairment from glare and light scattering with posterior capsule opacification. J Cataract Refract Surg. 1998;24:1626–1631. MEDLINE
25.. 25.Claesson M, Klaren L, Beckman C, et al. Glare and contrast sensitivity before and after Nd:YAG laser capsulotomy. Ada Ophthalmol jCopenhj. 1994;72:27–32.
26.. 26.Applegate RA, Trick LR, Meade DL, et al. Radial keratotomy increases the effects of disability glare: initialresults. Ann Ophthalmol. 1987;19:293–297. MEDLINE
27.. 27.Ghaith AA, Daniel J, Stulting RD, et al. Contrast sensitivity and glare disability after radial keratotomy and photorefractive keratectomy. Arch Ophthalmol. 1998;116:12–18. MEDLINE
28.. 28.Gartry DS, Kerr-Muir MG, Marshall J. Excimer laser photorefractive keratectomy: 18-month followup. Ophthal mology. 1992;99:1209–1219.
29.. 29.Diamond S. Excimer laser photorefractive keratectomy (PRK) for myopia—present status: aerospace considerations. Aviat Space Environ Med. 1995;66:690–693. MEDLINE
30.. 30.Ivan DJ, Tredici TJ, Perez-Becerra J, et al. Photorefractive keratectomy (PRK) in the military aviator: an aeromedical perspective. Aviat Space Environ Med. 1996;67:770–776. MEDLINE
31.. 31.el Danasoury MA. Prospective bilateral study of nightglare after laser in situ keratomileusis with single zone and transition zone ablation. J Refract Surg. 1998;14:512–516.
32.. 32.Novack GD. Ocular toxicology. Curr Opin Ophthalmol. 1994;5:110–114. MEDLINE |
CrossRef
33.. 33.Mathison IW, Haas KL. Drug photosensitivity. I. Light- and photo-sensitivities observed during oral contraceptive therapy. A review. Obstet Gynecol Surv. 1970;25:389–401. MEDLINE
34.. 34.Caffery BE, Josephson JE. Ocular side effects of isotretinoin therapy. J AM OPTOM ASSOC. 1988;59:221–224. MEDLINE
35.. 35.Adams AJ, Brown B. Alcohol prolongs time course of glare recovery. Nature. 1975;257:481–483. MEDLINE |
CrossRef
36.. 36.Adams AJ, Brown B, Haegerstrom-Portnoy G, et al. Marijuana, alcohol, and combined drug effects on the time course of glare recovery. Psychopharmacology (Berl). 1978;56:81–86. MEDLINE |
CrossRef
37.. 37.Aerospace medicine: flight surgeon's guide. Washington, DC: Department of the Air Force, 1968. Air Force Pamphlet No. 161-18.
38.. 38.Curtis JL. Visual problems of high altitude flight. In: Mercier A editors. Visual problems in aviation medicine. New York: The MacMillan Company; 1962;p. 39–44.
39.. 39.Nakagawara VB, Montgomery RW, Wood KJ. Aviation accidents and incidents associated with the use of ophthalmic devices by civilian pilots. Washington, DC: U.S. Department of Transportation/Federal Aviation Administration, 2001: FAA Report No. DOT/FAA/AM-01-14. (Available from: National Technical Information Service, Springfield, Virginia 22161. Order #ADA 396122.)
40.. 40.International Civil Aviation Organization. International standards and recommendation practices: aircraft accident and incident investigation, 9th ed. Chapter 1: Definitions. July 2001: 01/11/01. p. 1-1.
41.. 41.Swearingen JJ and Johnson GR. Strain patterns in aircraft windshield and visibility through polaroid sun glasses. Okla homa City, Okla.: United States Civil Aeronautic Administration, Aeronautical Center, Civil Aviation Medical Research Laboratories, 1948. Report No. AC 8500-1.